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a  b  s  t  r  a  c  t
INTRODUCTION:  Non-muscle  invasive  transtitional  cell  carcinoma  (TCC)  with  metastases  is exceedingly
rare.
PRESENTATION  OF  CASE:  We  report  the  case  of  a 78-year  old  man  with  an incidental  ﬁnding  of  a non-muscle
invasive  TCC  of the  left  distal  ureter during  treatment  for Duke’s  B  Colon  cancer.  Following  laparoscopic
nephro-ureterectomy  (LNU)  he  had  two  further  superﬁcial  recurrences  in  the  bladder  over a  14-montheywords:
on-muscle invasive
ransitional  cell carcinoma
ung  metastasis
period  which  underwent  transurethral  resection  (TUR).  On  surveillance  imaging  for  his  colorectal  cancer
follow-up  a lung  nodule  was  detected  and  video-assisted  thoracic  surgical  (VATS)  resection  of  the lesion
showed  it to  be  TCC  in origin.  He  was  referred  to  oncology  for chemotherapy  and  remains  clinically  well.
DISCUSSION:  A Literature  search  found  only  three  other  such  cases  and  the  ureteric  TCC  is the  most  likely
source  of  the  metastasis.
CONCLUSION:  This  occurrence  is exceedingly  rare.
gical 
pTa papillary TCC. The histology report speciﬁcally mentions the
absence of inﬁltration of underlying connective tissue or muscle
wall and there was no evidence of carcinoma in situ (CIS). The distal
 © 2013 Sur
. Introduction
Non-muscle invasive TCC with metastases is exceedingly rare.
n the bladder superﬁcial TCC can be conﬁned to the mucosa and is
taged Ta, or show invasion into the lamina propria, stage T1. The
resence of lympho-vascular invasion is seen as a poor prognostic
ndicator and is more commonly associated with muscle invasive
isease (stages T2, T3, T4) via which metastatic disease is able to
ccur. This is why  metastases in non-muscle invasive disease with-
ut any evidence of lympho-vascular invasion is so rare, yet we
eport a case of this very same occurrence.
. Presentation of case
A 78-year old gentleman presented to casualty four years ago
nder the general surgeons with a perforated caecal tumour for
hich he had an emergency right hemi-colectomy. The histology
as Duke’s B, T4 N0 M0  adenocarcinoma of the caecum. Post-
perative CT scan revealed an incidental ﬁnding of marked left
ydronephrosis and hydroureter and no lung metastasis (Fig. 1) and
 CT urogram conﬁrmed the presence of a ﬁlling defect in the left
istal ureter (Fig. 2). After 8 weeks of convalescence and adjuvant
hemotherapy following his bowel surgery he had a cystoscopy
hich did not show any intravesical abnormalities but on diagnos-
ic ureteroscopy there was a papillary lesion in the left distal ureter.
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A biopsy was taken and the histology was  Grade 2, Ta papillary TCC.
Four weeks later he underwent a left LNU and endoscopic resection
of the left ureteric oriﬁce and the histology conﬁrmed Grade 2,
Open access under CC BY-NC-ND license.Fig. 1. Initial CT thorax.
Y-NC-ND license. 
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hFig. 2. CT urogram demonstrating ﬁlling defect in left distal ureter.
reteric margin and left ureteric oriﬁce specimens were microscop-
cally clear of tumour. He was discharged home four days later and
 cystogram two weeks post-operatively showed no evidence of
eak.
This gentleman was now in a programme of regular endoscopic
urveillance and his ﬁrst check four months after his LNU revealed
uperﬁcial-looking papillary tumour at the bladder neck and left
ateral wall. These were resected and he had one dose of intravesical
itomycin C (MMC)  post-op. The histology again conﬁrmed Grade
, pTa papillary TCC of the bladder. Further check cystoscopy at
ourteen months again showed recurrence at the bladder neck and
rostatic urethra. These were resected showing further Grade 2,
Ta papillary TCC so he had a six-week course of intravesical MMC.
e has not had any further recurrences to date.
Meanwhile, this patient was still undergoing regular GI follow-
p with cross-sectional imaging and 3 years following his right
emi-colectomy his CT scan showed an 8.5 mm nodule in the left
Fig. 3. CT thorax showing left apical lung metastasis.PEN  ACCESS
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apex of the lung suspicious for a possible pulmonary metastasis.
Referral to the respiratory multi-disciplinary team advised a repeat
CT scan in 4 months and this showed the nodule had increased in
size to 10.5 mm (Fig. 3) and likely to be a pulmonary metastasis.
He underwent video-assisted thoracic surgical (VATS) resection of
this apical lung nodule to determine the tumour primary and this
conﬁrmed TCC. He has been referred to oncology for a full course of
chemotherapy and remains without recurrence of his caecal ade-
nocarcinoma.
3. Discussion
An extensive pubmed literature search yielded eight cases of
metastatic superﬁcial bladder cancer and of these, three reported
lung metastasis. Hirayama et al.1 reported the case of a 66-year old
woman with a history of low-grade superﬁcial bladder tumours
who presented with a coin-sized lesion in the right lung. Tho-
racoscopic partial pneumonectomy revealed metastatic TCC and
recurrent bladder tumours were found in the bladder on cysto-
scopic follow-up. Dougherty et al.2 reported on a case series of two
patients with low grade non-muscle invasive TCC of the bladder
and pulmonary metastases. The ﬁrst case described a 78-year old
male with recurrent superﬁcial low grade TCC after failed bacille
Calmette Guerin (BCG) therapy who went on to develop lung
metastases 10 years from his initial diagnosis of bladder cancer.
This was  conﬁrmed histologically following right middle lobectomy
3 years after carboplatin-based chemotherapy gave only a partial
response the growth of the metastases. The second case was that
of a 61-year old male investigated for a lung lesion 8 years after left
nephroureterectomy for low grade superﬁcial TCC in his ureter and
renal pelvis. This was followed by recurrent low grade superﬁcial
bladder tumours in the intervening years. Right lower lobectomy
conﬁrmed the diagnosis of metastatic TCC and the patient went on
to receive adjuvant carboplatin-based chemotherapy as well.
Other sites of metastasis from non-invasive bladder cancer
include the ovary3 in a 60-year old woman  with an abdominal mass
who had a Grade 3 TCC metastasis on her left ovary 4 years after
initial TUR resection for Grade 2 superﬁcial TCC of the bladder. She
later progressed and developed pelvic metastases and died. The
only other case with a distant site of metastasis from non-muscle
invasive TCC bladder was  published by Shikishima et al. in 1989.4
In this case a 74-year old man  presented with a 2-week history
of red eye and diplopia 3 years after undergoing TUR for Grade 2
superﬁcial TCC of the bladder. A trans-septal anterior orbitotomy
revealed nests of carcinomatous cells conﬁrmed histologically as
TCC. More regional sites of non-muscle invasive TCC bladder metas-
tases include the uterine corpus of a 78-year old woman who had
TUR of a bladder tumour for Grade 3, pT1 disease 2 years earlier,5
and vaginal implantation of Grade 2 non-muscle invasive TCC in
an 82-year old woman 10 years after TUR of the same histological
lesion from the bladder. Interestingly, the authors proposed that
vaginal implantation of TCC may  have occurred via irrigation ﬂuid
during TUR or from patient’s urine.
The interesting question in this case is what is the likely source
of the metastasis – ureter or bladder? Our opinion is that the ureter
is the more likely primary for the metastasis as the papillary tumour
was more extensive and had been present for longer compared to
the very superﬁcial-looking bladder tumour picked up at the ﬁrst
check ﬂexible cystoscopy. Histologically, there is also the possibility
that muscle invasion was missed on analysis of the nephroureteric
tissue.4. Conclusion
Our case highlights a rare incidence of distant metastatic non-
muscle invasive bladder cancer in an elderly man. Using the
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uropean Organisation for Research and Treatment of Cancer
EORTC) risk stratiﬁcation tables6 his probability of recurrence at 1
nd 5 years was intermediate at 38.0% and 62.0%, respectively. The
robability of progression at 1 and 5 years (i.e. to muscle-invasive
isease) also fell in the intermediate category at only 1.0% and 6.0%,
espectively. His progression was detected at 3 years which fur-
her highlights how unlikely the progression to metastatic disease
as. Cross-sectional imaging of the thorax is not routinely used in
ur urology department for follow-up of non-muscle invasive TCC,
herefore, had this patient not been having such surveillance as part
f his colorectal follow-up his lung metastasis would likely not have
een found until he became symptomatic with chest symptoms or
ndeed metastatic disease elsewhere.
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Initially, TF Chen had identiﬁed this case. Both N Nkwam and TF
Chen reviewed the patient in clinical setting and discussed litera-
ture review, and Nkwam performed literature search. After getting
guidance from Chen for the write-up, Nkwam sourced case notes
and wrote case report. Finally, Chen obtained consent from the
patient for publication.
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